Centers for Disease Control and Prevention (CDC)
Evaluation of Genomic Applications in Practice and Prevention (EGAPP). An initiative to develop and implement a systematic, evidence-based process for assessing genetic tests. Builds on CDC-funded ACCE model process.
Note on web sites affiliated with
EGAPP Stakeholders Group (ESG) members
ESG members represent a diversity of genetic testing stakeholder organizations,
whose web sites also may be of interest to visitors to this web site.
For a complete listing of ESG affiliations, visit the ESG web pages
on the web site for the Centers for Disease Control and Prevention.
Page last updated: May 15, 2013
Page last reviewed: May 15, 2013
Content Source: OPHG Staff